- Sprache
-
Englisch
- Identifier
-
1268710792
Beteiligte Personen und Organisationen
Acharya, Pragyan
Chouhan, Komal
Weiskirchen, Sabine
Weiskirchen, Ralf
Chouhan, Komal
Weiskirchen, Sabine
Weiskirchen, Ralf
- DOI
-
10.18154/RWTH-CONV-249169
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
27.10.2022, 11:05 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Acharya, Pragyan
- Chouhan, Komal
- Weiskirchen, Sabine
- Weiskirchen, Ralf
Ähnliche Objekte (12)
Mechanisms of liver fibrosis resolution
Mechanisms Underlying Cell Therapy in Liver Fibrosis : An Overview
Liver Fibrosis : From Mechanisms of Injury to Modulation of Disease
Liver fibrosis and endocannabinoids
Fibrosis remodelling and ECM biomarkers in liver fibrosis
Endothelial regulation of liver fibrosis
Cell therapy in liver fibrosis
Brg1 modulates liver regeneration and promotes liver fibrosis
Molecular mechanisms underlying the protective effect of MIF in experimental liver fibrosis
Molecular mechanisms underlying the protective effect of MIF in experimental liver fibrosis
Chemokines as inflammatory mediators of fibrosis in liver fibrosis
Endoglin in human liver disease and murine models of liver fibrosis : a protective factor against liver fibrosis
Mechanisms of liver fibrosis resolution
Mechanisms Underlying Cell Therapy in Liver Fibrosis : An Overview
Liver Fibrosis : From Mechanisms of Injury to Modulation of Disease
Liver fibrosis and endocannabinoids
Fibrosis remodelling and ECM biomarkers in liver fibrosis
Endothelial regulation of liver fibrosis
Cell therapy in liver fibrosis
Brg1 modulates liver regeneration and promotes liver fibrosis
Molecular mechanisms underlying the protective effect of MIF in experimental liver fibrosis
Molecular mechanisms underlying the protective effect of MIF in experimental liver fibrosis
Chemokines as inflammatory mediators of fibrosis in liver fibrosis
Endoglin in human liver disease and murine models of liver fibrosis : a protective factor against liver fibrosis
Mechanisms of liver fibrosis resolution
Mechanisms Underlying Cell Therapy in Liver Fibrosis : An Overview
Liver Fibrosis : From Mechanisms of Injury to Modulation of Disease
Liver fibrosis and endocannabinoids
Fibrosis remodelling and ECM biomarkers in liver fibrosis
Endothelial regulation of liver fibrosis
Cell therapy in liver fibrosis
Brg1 modulates liver regeneration and promotes liver fibrosis
Molecular mechanisms underlying the protective effect of MIF in experimental liver fibrosis
Molecular mechanisms underlying the protective effect of MIF in experimental liver fibrosis
Chemokines as inflammatory mediators of fibrosis in liver fibrosis